BBTV

About Us

all episodes

Allogeneic or Autologous? – Stem Cell Review (EP2)

Chapters 1. Technology & Business Models 2. Intellectual Property 3. Regulatory Concerns 4. Transplantation & Immune Rejection 1. Technology & Business Models 2. Intellectual Property 3. Regulatory Concerns 4. Transplantation & Immune Rejection Reviewing the technology, business models, intellectual property, regulatory concerns, transplantation and immune rejection. This is the Episode 2 of the Stem Cell Review, aired on October 8st, 2009

Stem Cells at a Glance – Stem Cell Review (EP1)

Chapters 1. Different Types of Stem Cells & Future Medical Applications 2. Stem Cell Interaction and the iPS Cell Revolution 3. The Business & Politics of Stem Cells 1. Different Types of Stem Cells & Future Medical Applications What are the differences between embryonic, adult and induced pluripotent stem cells? Where do the experts expect the next medical application will ...

Vaccine and Antibody Production from Stem Cells, Vivalis

Vivalis uses Embryonic Stem Cell Technology to Enable Vaccine and Antibody Production. Chicken eggs revolutionized the production of vaccines. Could animal stem cells be the new chicken egg? Vivalis has created a technology platform based on embryonic stem cells that enables the production of vaccines and antibodies. Vivalis’ CSO Majid Mehtali is interviewed by Reni Benjamin, ...

  • Series

    • The Stem Cell Review

  • Shows

    • Biotech in the Money
    • Wall Street On BBTV
    • Science Breakthrough
    • The Jan Buck Show
    • 60sec Pitches
    • Special Interview
    • Report on Location
  • ABOUT BIOBUSINESS.TV
  • BioBusiness.TV is the first independent Internet TV Network for biotechnology professionals. We create and syndicate video-based industry focused shows and series that range from scientific breakthroughs, to equity analyst insights, as well as C-level executive and investor interviews on strategy, management, policy, marketing, science and more. We strive to enhance the quality and accessibility of industry video programming, and to deliver information biotechnology professionals can rely on to make sound and informed decisions.
  • PARTNERING WITH BIOBUSINESS.TV
  • If you’ve got great video programs and a growing audience, let BioBusiness.TV help you take it to the next level through our Partner Program. You can reach out to us through our ‘contact us’ page.
  • DISCLAIMER
  • Viewers should verify all claims and do their own due diligence before investing in any securities mentioned on BioBusiness.TV.